Activation of the GLP-1 receptor in microglia, GABAergic interneurons and astrocytes stimulates several intracellular pathways including the PI3K/Akt, cAMP/PKA/CREB, and P-Akt/p-eNOS and subsequently confers neuroprotective effects through inhibition of gp91/CHOP, Nrf2/HO-1, Bax/Bcl-2/caspase3/PARP, NF-B/ICAM-1, and JAK2/STAT3
This back-and-forth cycle can easily add weeks to your timeline, frustrating both patients and healthcare providers working to access the most effective treatment available
Together, theyre not just enhancing your stamina but also protecting your heart and speeding up muscle recovery
Here, we examine the contribution of peptide agonist conformational plasticity to activation of the glucagon-like peptide 1 receptor (GLP-1R), an important clinical target